Genmab A/S (GE9.F)

EUR 194.65

(2.93%)

Operating Income Summary of Genmab A/S

  • Genmab A/S's latest annual operating income in 2023 was 713.6 Million EUR , down -15.59% from previous year.
  • Genmab A/S's latest quarterly operating income in 2024 Q2 was 242.95 Million EUR , up 126.8% from previous quarter.
  • Genmab A/S reported an annual operating income of 845.37 Million EUR in 2022, up 108.32% from previous year.
  • Genmab A/S reported an annual operating income of 405.8 Million EUR in 2021, down -52.15% from previous year.
  • Genmab A/S reported a quarterly operating income of 242.95 Million EUR for 2024 Q2, up 126.8% from previous quarter.
  • Genmab A/S reported a quarterly operating income of 229.67 Million EUR for 2023 Q3, up 14.54% from previous quarter.

Annual Operating Income Chart of Genmab A/S (2023 - 2016)

Historical Annual Operating Income of Genmab A/S (2023 - 2016)

Year Operating Income Operating Income Growth
2023 713.6 Million EUR -15.59%
2022 845.37 Million EUR 108.32%
2021 405.8 Million EUR -52.15%
2020 848.12 Million EUR 140.24%
2019 353.02 Million EUR 90.86%
2018 184.96 Million EUR 0.79%
2017 183.52 Million EUR 29.61%
2016 141.59 Million EUR 0.0%

Peer Operating Income Comparison of Genmab A/S

Name Operating Income Operating Income Difference
ADV.BLOCKCHAIN AG INH ON 1.74 Million EUR -40778.343%
Branicks Group AG - EUR -Infinity%
aifinyo AG 2.2 Million EUR -32336.426%
The Platform Group AG 13.73 Million EUR -5096.772%